Clinical Trials Sponsored by Biomedical Development Corporation

Total 250 results

GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Biomedical Development Corporation

Completed

mHealth for Patient Self-Management of Opioid Use Disorder

Opioid-use Disorder

United States
OptiScan Biomedical Corporation

Unknown

MANAGE Automated Glucose Monitoring (MANAGE IDE)

ICU/CCU Patients Requiring Blood Glucose Monitoring

United States
Biomedical Development Corporation
National Institute of Nursing Research (NINR)

Completed

Pilot Efficacy Study to Treat Gingivitis

Gingival Diseases

United States
ID Biomedical Corporation, Quebec

Unknown

Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.

Influenza

United States
ID Biomedical Corporation, Quebec

Completed

Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

Influenza

United States
GlaxoSmithKline
ID Biomedical Corporation, Quebec

Completed

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

Influenza
University of Cincinnati
Biomedical Advanced Research and Development Authority; Cerus Corporation

Unknown

Recovery and Lifespan of Red Blood Cells From Pathogen-reduced, Stored Blood Units (BIO-CR-RBC)

Red Cell Survival in Healthy Volunteers

United States
Ortho Development Corporation

Recruiting

Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System

Joint Diseases | Rheumatoid Arthritis | Osteoarthritis, Hip | Psoriatic Arthritis | Avascular Necrosis of Hip

United States
OptiScan Biomedical Corporation
Erasme University Hospital

Completed

OptiScanner Versus Standard Blood Glucose Monitoring

Hyperglycemia

Belgium
Biomedical Advanced Research and Development Authority

Completed

Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59

Influenza A Virus, H5N1 Subtype

United States
The University of Texas Health Science Center at...
Biomedical Development Corporation

Completed

Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods

Bipolar Disorder

United States
Biomedical Development Corporation
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Novel Topical Treatment of Hand Dermatitis (Eczema)

Contact Dermatitis | Eczema, Contact

United States
Biomedical Development Corporation
National Heart, Lung, and Blood Institute (NHLBI); University of Kentucky

Unknown

Efficacy of Iocide Oral Rinse Against Gingival Inflammation

Gingivitis | Investigation of Biological Markers of Inflammation

United States
Biomedical Development Corporation
National Heart, Lung, and Blood Institute (NHLBI); University of Texas

Completed

Dose-Response Study of Iocide Oral Rinse

Gingivitis

United States
CMED HIFU Development Corporation

Suspended

High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain (HIFU Pancreas)

Pain | Pancreatic Adenocarcinoma | Ductal Adenocarcinoma

United States
River Vision Development Corporation

Completed

A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States
Biomedical Development Corporation
National Institute of Dental and Craniofacial Research (NIDCR); University...

Completed

Novel Rinse to Treat in Oral Candidiasis in Cancer Patients

Candidiasis | Candidiasis, Oral | Thrush

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Completed

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

Infections, Bacterial

United States
Biomedical Advanced Research and Development Authority
PPD

Completed

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

A/Vietnam/H5N1 Influenza Virus

United States
Vaxart
Biomedical Advanced Research and Development Authority

Completed

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Influenza

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Completed

Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)

Infections, Bacterial

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Terminated

A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough

Cough

United Kingdom
Cooperative Research Centre for Biomedical Imaging...

Unknown

Of 18F MEL050 Using PET/CT in Metastatic Melanoma (MEL050)

Metastatic Melanoma

Australia
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Terminated

Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model

Healthy Volunteers

Germany
Seqirus
Biomedical Advanced Research and Development Authority

Completed

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Avian Influenza

United States
Energenesis Biomedical Co., Ltd.
A2 Healthcare Taiwan Corporation

Completed

ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

Diabetes Mellitus | Diabetic Foot | Foot Ulcer | Wounds

Taiwan
Memorial Sloan Kettering Cancer Center
Nova Biomedical Corporation

Completed

Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device

Cancer

United States
Profil Institut für Stoffwechselforschung GmbH
OptiScan Biomedical Corporation

Completed

Performance Study Using the OptiScanner on Healthy Diabetics

Diabetes

Germany
Washington University School of Medicine
OptiScan Biomedical Corporation

Terminated

Glucose Time-In-Range Development Evaluation (GIDE)

Dysglycemia | ICU

United States
Energenesis Biomedical Co., Ltd.
A2 Healthcare Taiwan Corporation

Completed

ENERGI-F701 for Female Hair Loss Treatment

Alopecia | Hair Loss | Female Pattern Baldness

Taiwan
Biomedical Development Corporation
Methodist Healthcare Ministries of South Texas; Foundation Of Collaborative...

Completed

Exploratory Study of Iocide Oral Rinse in a Diabetic Population (Diabetes)

Periodontitis | Diabetes Type 2

United States
Matrivax Research and Development Corporation

Active, not recruiting

A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine

Pneumococcal Vaccine

United States
Matrivax Research and Development Corporation

Completed

Safety and Immunogenicity of Typhax, a Typhoid Vaccine

Typhoid Fever
Midwest Biomedical Research Foundation
Olympus Corporation of the Americas

Recruiting

Endosonographic Shear Wave Elastography for Liver Stiffness

Liver Cirrhosis

United States
Evidation Health
Biomedical Advanced Research and Development Authority

Recruiting

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections (WAVE)

COVID-19 | Influenza, Human | Influenza A | Respiratory Syncytial Virus (RSV) | Influenza B

United States
Invirsa, Inc.
Biomedical Advanced Research and Development Authority

Recruiting

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Acute Infectious Keratoconjunctivitis

United States, Thailand
T2 Biosystems
Biomedical Advanced Research and Development Authority

Active, not recruiting

T2Resistance - Detection of Resistance Related Genes

Resistance Bacterial

United States
Visterra, Inc.
Biomedical Advanced Research and Development Authority

Completed

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

Influenza

United States, Estonia, South Africa, Bulgaria, Serbia, Ukraine, Latvia
Terumo BCTbio
Biomedical Advanced Research and Development Authority

Terminated

Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia (MIPLATE)

Hematologic Malignancies | Hypoproliferative Thrombocytopenia

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

Zika Virus

United States, Puerto Rico
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects

Zika Virus

United States
SIGA Technologies
Biomedical Advanced Research and Development Authority

Completed

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat (SIGA246-008)

Smallpox

United States
TVAX Biomedical
FDA Office of Orphan Products Development

Recruiting

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme of Brain

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Active, not recruiting

A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 (TeenCove)

SARS-CoV-2

United States, Dominican Republic
Duke University
Biomedical Advanced Research and Development Authority

Enrolling by invitation

Infection Watch Study (CovIdentify)

Respiratory Syncytial Virus Infections | COVID-19 Respiratory Infection | Influenza Viral Infections | Rhinoviral Infections

United States
Avita Medical
Biomedical Advanced Research and Development Authority

Terminated

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

Burns

United States
Current Health
Biomedical Advanced Research and Development Authority

Terminated

Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization (RiskSEARCH)

Covid19

United States
Avita Medical
Biomedical Advanced Research and Development Authority

Terminated

RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

Skin; Deformity

United States
Cytovale, Inc.
Biomedical Advanced Research and Development Authority

Active, not recruiting

SQuISH-COVID: A Pilot Study

COVID-19 | Sepsis

United States

Clinical Trials Sponsored by Biomedical Development Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations